Join us on Thursday, September 17, for a free, live presentation by Robert Meisner, MD, to explore what is currently known about ketamine and esketamine, including how these treatments work, who may benefit from them, potential risks, and what treatment can look like in practice. Discussion will include ketamine-assisted psychotherapy, including how psychotherapy may complement medication treatment and what researchers do, and do not, know about the potential benefits of combining the two. Looking beyond ketamine, we’ll discuss emerging psychedelic-based treatments and new therapies currently being studied for depression, anxiety, and other mental health conditions. Throughout the presentation, we’ll distinguish established scientific evidence from promising but unproven theories. Our goal is to separate hope from hype and provide a clear, evidence-informed look at where mental health treatment may be headed. By the end of this webinar, participants will be able to:
- Explain the differences between ketamine and esketamine, including how they work, potential benefits and risks, and what treatment may involve.
- Describe current approaches to ketamine-assisted psychotherapy and distinguish established evidence from theories and practices that have not yet been adequately studied.
- Discuss emerging psychedelic-based treatments and other novel therapies being studied for depression, anxiety, and related mental health conditions, including what is known about their potential benefits and limitations.
|
Nema komentara:
Objavi komentar